Therapeutic Landscape of Carfilzomib and Other Modulators of the Ubiquitin-Proteasome Pathway

Ítems similars

• Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications
  per: Huang, Qian, et al.
  Publicat: (2010)
• The Ubiquitin-Proteasome Pathway and Proteasome Inhibitors
  per: Myung, Jayhyuk, et al.
  Publicat: (2001)
• The ubiquitin-proteasome pathway in cancer.
  per: Spataro, V., et al.
  Publicat: (1998)
• Activin-β(C) modulates cachexia by repressing the ubiquitin-proteasome and autophagic degradation pathways
  per: Marino, Francesco Elia, et al.
  Publicat: (2015)
• Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma
  per: Kuhn, Deborah J., et al.
  Publicat: (2007)